{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-063416","form_type":"8-K","ticker":"TELA","cik":"0001561921","company_name":"TELA Bio, Inc.","filed_at":"2024-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.967419+00:00","generated_at":"2026-06-01T12:39:31.046040+00:00","sec_items":["8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"TELA Bio appoints Greg Firestone as CCO, replaces Peter Murphy terminated without cause","bullets":["Greg Firestone appointed Chief Commercial Officer effective May 20, 2024; previously Chief Business Officer since October 2017.","Peter Murphy terminated as CCO without cause on May 19, 2024; will receive severance per his employment agreement.","Firestone will oversee commercial operations, product launches, sales training, and market access strategy.","Firestone brings 35+ years of healthcare experience, including founding the IDN Summit & Expo."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-063416","json":"https://secwatch.observer/filing/0001104659-24-063416.json","markdown":"https://secwatch.observer/filing/0001104659-24-063416.md","text":"https://secwatch.observer/filing/0001104659-24-063416.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1561921/000110465924063416/0001104659-24-063416-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1561921/000110465924063416/tm2414892d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T12:39:31.046040+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}